Gastroesophageal Junction Cancer
📧 Sign up to get email alerts when something new happens for Gastroesophageal Junction Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma [EARLY_Phase 1]
This update notes the completion of an early Phase 1 trial evaluating adjuvant chemoradiation therapy for gastric cancer and gastroesophagea…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery [Phase 1]
Phase 1 trial update of gefitinib with cisplatin and irinotecan (with radiation therapy) as neoadjuvant treatment for esophageal cancer or g…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial update for a multimodal approach (chemotherapy, radiation, cetuximab, followed by surgery, then docetaxel and cetuximab) in es…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: T900607 in Treating Patients With Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial update for the agent T900607 in patients with gastric cancer and gastroesophageal junction cancer; the study status i…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial updates on erlotinib for locally advanced or metastatic stomach cancer and gastroesophageal junction cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 1]
A Phase 1 study investigated the safety and dosing of a combination chemotherapy and radiation therapy regimen for esophageal cancer and gas…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]
A Phase 2 trial tested arsenic trioxide in advanced esophageal and gastroesophageal junction cancers. The study was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer [Phase 1]
A Phase 1 clinical trial update announcing completion of a study of the monoclonal antibody ABX-EGF in patients with multiple cancers, inclu…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer [Phase 1, Phase 2]
An open-label Phase 1/2 study evaluating chemoradiotherapy with AT-101 in locally advanced esophageal or gastroesophageal junction cancer wa…
-
CLINICAL_TRIALS research · 2012-12-12Clinical Trial Update: Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 trial update evaluating cisplatin, docetaxel, and S-1 for advanced gastric cancer and gastroesophageal junction cancer. The trial …
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating fluorouracil, oxaliplatin, and leucovorin in patients with metastatic gastric cancer or gastroesophageal junction c…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction [Phase 2]
A Phase 2 trial of pegamotecan for gastric and gastroesophageal junction cancers was terminated; the update does not include reported effica…
-
CLINICAL_TRIALS withdrawal · 2012-05-28Clinical Trial Update: Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
A clinical trial on collection of biospecimens and clinical information from patients with gastrointestinal and gynecologic cancers was with…
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating cetuximab in metastatic esophageal cancer or gastroesophageal junction cancer has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction [Phase 2]
A Phase 2 SWOG trial evaluating a multimodal regimen of oxaliplatin, 5-fluorouracil, radiation therapy, and surgery for stage II-III esophag…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 clinical trial evaluating Gefitinib for recurrent or metastatic esophageal or gastroesophageal junction cancer has completed, with…
-
CLINICAL_TRIALS research · 2011-11-23Clinical Trial Update: Quality of Life With Esophageal Stent Trial [NA]
Clinical trial update evaluating quality of life for patients with esophageal cancer or gastroesophageal junction cancer treated with an eso…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Diagnostic Value of C-reactive Protein for Detection of Postoperative Inflammatory Complications After Gastroesophageal Cancer Surgery
A completed clinical trial assesses the diagnostic value of C-reactive protein for detecting postoperative inflammatory complications after …
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer [Phase 2]
Phase 2 trial evaluating the combination of docetaxel (Taxotere), cisplatin, and irinotecan (CPT-11) for esophagogastric cancers has been co…